IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
$10.28
+10.83% today · +21.86% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- IBRX +10.83% on the last session vs SPY +0.74%: +10.1 pts of stock-specific move.
- Aftermath, rsi overbought (Oct 2): After its 11 overbought readings in the past 5 years, IBRX typically lost 5.3% over the next month (median) and was higher only 45% of the time; half the outcomes fell between -16.9% and +32.6%. An ordinary month: -1.8%. Among S&P 500 stocks after overbought readings, that ranks #263 of 501.
- 0 Reddit mentions in the past 24 hours, 81% positive over the week · today's pace is 1.5× its recent daily average.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Meta Analyst score · Buy (+1.18)
Every firm's latest rating in the past year, each weighted by its age (a 3-month-old call counts half as much as today's), blended with the consensus of 3 analysts (+1.33, counted like 1.5 fresh ratings). 5 firms, 0 with a call in the past 3 months.
| Firm | Latest rating | Date | Weight |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Jun 2, 2026 | 13% |
| BTIG | Buy | May 21, 2026 | 12% |
| D. Boral Capital | Buy | May 5, 2026 | 11% |
| Piper Sandler | Overweight | Mar 4, 2026 | 7% |
| Jefferies | Buy | Dec 12, 2025 | 4% |
Mean target
$13.00
+26.4% upside
Median target
$12.00
+16.7% upside
Target range
12.00–15.00
low to high
Analysts
3
as of Oct 5
Price vs. targets
Low $12
Mean $13
High $15
Now $10.28
Consensus
Strong buy 1Buy 2Hold 0Sell 0Strong sell 0
Rating and target changes
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| Jun 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | $15.00 |
| May 21, 2026 | BTIG | Reiterated | Buy | $12.00 |
| May 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | $15.00 |
| May 5, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Apr 21, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Apr 8, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Mar 26, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Mar 23, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Mar 17, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Mar 9, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Mar 4, 2026 | Piper Sandler | Raised target | Overweight | $7.00 → $12.00 |
| Feb 23, 2026 | HC Wainwright & Co. | Raised target | Buy | $10.00 → $15.00 |
| Feb 23, 2026 | D. Boral Capital | Reiterated | Buy | $23.00 |
| Feb 19, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Feb 17, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Jan 26, 2026 | HC Wainwright & Co. | Raised target | Buy | $8.00 → $10.00 |
| Jan 23, 2026 | BTIG | Raised target | Buy | $6.00 → $9.00 |
| Jan 23, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Jan 20, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Jan 20, 2026 | Piper Sandler | Raised target | Overweight | $5.00 → $7.00 |
| Jan 16, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Jan 13, 2026 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Dec 16, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Dec 12, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Dec 12, 2025 | Jefferies | Raised target | Buy | $8.00 → $9.00 |
| Dec 11, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Nov 13, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Nov 5, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
| Sep 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | $8.00 |
| Sep 8, 2025 | D. Boral Capital | Reiterated | Buy | $24.00 |
Source: Yahoo Finance analyst data, collected daily.